Interferon-β-induced activation of c-Jun NH2-terminal kinase mediates apoptosis through up-regulation of CD95 in CH31 B lymphoma cells

Experimental Cell Research

Volumn 304, Issue 2, 2005, Pages 518-530

  Takada, Eiko ^a   Shimo, Kuniaki ^a   Hata, Kikumi ^a   Abiake, Maira ^a   Mukai, Yasuo ^a   Moriyama, Masami ^b   Heasley, Lynn ^c   Mizuguchi, Junichiro ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Apoptosis; B lymphocytes; c Jun NH2 Terminal Kinase; CD95; Interferon; Rodent

Indexed keywords

BETA INTERFERON; CASPASE 8; FAS ANTIGEN; LACTACYSTIN; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL CELL; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CONCENTRATION RESPONSE; DOWN REGULATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

EID: 14644429045     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2004.11.015     Document Type: Article

References (57)

1. I.M. Grumbach, E.N. Fish, S. Uddin, B. Majchrzak, O.R. Colamonici, H.R. Figulla, A. Heim, and L.C. Platanias Activation of the Jak-Stat pathway in cells that exhibit selective sensitivity to the antiviral effects of IFN-beta compared with IFN-alpha J. Interferon Cytokine Res. 19 1999 797 801
2. J.U. Gutterman Cytokine therapeutics: lessons from interferon alpha Proc. Natl. Acad. Sci. U. S. A. 91 1994 1198 1205
3. J. Salmeron, A. Ruiz-Extremera, C. Torres, L. Rodriguez-Ramos, I. Lavin, D. Quintero, and A. Palacios Interferon versus ribavirin plus interferon in chronic hepatitis C previously resistant to interferon: a randomized trial Liver 19 1999 275 280
4. D.W. Paty, and D.K. Li Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group Neurology 43 1993 662 667
5. N.S. Thomas Regulation of the product of a possible human cell cycle control gene CDC2Hs in B-cells by alpha-interferon and phorbol ester J. Biol. Chem. 264 1989 13697 13700
6. R. Kumar, and I. Atlas Interferon alpha induces the expression of retinoblastoma gene product in human Burkitt lymphoma Daudi cells: role in growth regulation Proc. Natl. Acad. Sci. U. S. A. 89 1992 6599 6603
7. M. Einat, D. Resnitzky, and A. Kimchi Close link between reduction of c-myc expression by interferon and, G0/G1 arrest Nature 313 1985 597 600
8. C. Selleri, T. Sato, L. Del Vecchio, L. Luciano, A.J. Barrett, B. Rotoli, N.S. Young, and J.P. Maciejewski Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-alpha in chronic myelogenous leukemia Blood 89 1997 957 964
9. H. Spets, P. Georgii-Hemming, J. Siljason, K. Nilsson, and H. Jernberg-Wiklund Fas/APO-1 (CD95)-mediated apoptosis is activated by interferon-gamma and interferon- in interleukin-6 (IL-6)-dependent and IL-6-independent multiple myeloma cell lines Blood 92 1998 2914 2923
10. S.A. Buechner, M. Wernli, T. Harr, S. Hahn, P. Itin, and P. Erb Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas)-CD95 ligand-induced suicide J. Clin. Invest. 100 1997 2691 2696
11. W. Roth, B. Wagenknecht, J. Dichgans, and M. Weller Interferon-alpha enhances CD95L-induced apoptosis of human malignant glioma cells J. Neuroimmunol. 87 1998 121 129
12. Q. Chen, B. Gong, A.S. Mahmoud-Ahmed, A. Zhou, E.D. Hsi, M. Hussein, and A. Almasan Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma Blood 98 2001 2183 2192
13. K. Oshima, N. Yanase, C. Ibukiyama, A. Yamashina, N. Kayagaki, H. Yagita, and J. Mizuguchi Involvement of trail/trail-r interaction in ifn-alpha-induced apoptosis of Daudi b lymphoma cells Cytokine 14 2001 193 201
14. M. Chawla-Sarkar, D.W. Leaman, and E.C. Borden Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines Clin. Cancer Res. 7 2001 1821 1831
15. T. Timmer, E.G. de Vries, and S. de Jong Fas receptor-mediated apoptosis: a clinical application? J. Pathol. 196 2002 125 134
16. S. Nagata Fas ligand-induced apoptosis Annu. Rev., Genet. 33 1999 29 55
17. H. Wajant The Fas signaling pathway: more than a paradigm Science 296 2002 1635 1636
18. C. Scaffidi, S. Fulda, A. Srinivasan, C. Friesen, F. Li, K.J. Tomaselli, K.M. Debatin, P.H. Krammer, and M.E. Peter Two CD95 (APO-1/Fas) signaling pathways EMBO J. 17 1998 1675 1687
19. S.A. Susin, N. Zamzami, and G. Kroemer Mitochondria as regulators of apoptosis: doubt no more Biochim. Biophys. Acta 1366 1998 151 165
20. C. Scaffidi, I. Schmitz, P.H. Krammer, and M.E. Peter The role of c-FLIP in modulation of CD95-induced apoptosis J. Biol. Chem. 274 1999 1541 1548
21. M. Thome, and J. Tschopp Regulation of lymphocyte proliferation and death by FLIP Nat. Rev., Immunol. 1 2001 50 58
22. M. Irmler, M. Thome, M. Hahne, P. Schneider, K. Hofmann, V. Steiner, J.L. Bodmer, M. Schroter, K. Burns, C. Mattmann, D. Rimoldi, L.E. French, and J. Tschopp Inhibition of death receptor signals by cellular FLIP Nature 388 1997 190 195
23. P. Domanski, and O.R. Colamonici The type-I interferon receptor. The long and short of it Cytokine Growth Factor Rev. 7 1996 143 151
24. M. Gadina, D. Hilton, J.A. Johnston, A. Morinobu, A. Lighvani, Y.J. Zhou, R. Visconti, and J.J. O'Shea Signaling by type I and II cytokine receptors: ten years after Curr. Opin. Immunol. 13 2001 363 373
25. T. Taniguchi, and A. Takaoka A weak signal for strong responses: interferon-alpha/beta revisited Nat. Rev., Mol. Cell Biol. 2 2001 378 386
26. M. David, E. Petricoin III, C. Benjamin, R. Pine, M.J. Weber, and A.C. Larner Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins Science 269 1995 1721 1723
27. I.A. Mayer, A. Verma, I.M. Grumbach, S. Uddin, F. Lekmine, F. Ravandi, B. Majchrzak, S. Fujita, E.N. Fish, and L.C. Platanias The p38 MAPK pathway mediates the growth inhibitory effects of interferon-alpha in BCR-ABL-expressing cells J. Biol. Chem. 276 2001 28570 28577
28. M. Caraglia, A. Abbruzzese, A. Leardi, S. Pepe, A. Budillon, G. Baldassare, C. Selleri, S.D. Lorenzo, A. Fabbrocini, G. Giuberti, G. Vitale, G. Lupoli, A.R. Bianco, and P. Tagliaferri Interferon-alpha induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway that is antagonized by epidermal growth factor Cell Death Differ. 6 1999 773 780
29. L. Chang, and M. Karin Mammalian MAP kinase signalling cascades Nature 410 2001 37 40
30. Y.R. Chen, and T.H. Tan The c-Jun N-terminal kinase pathway and apoptotic signaling (review) Int. J. Oncol. 16 2000 651 662
31. Z. Xia, M. Dickens, J. Raingeaud, R.J. Davis, and M.E. Greenberg Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis Science 270 1995 1326 1331
32. R.J. Davis Signal transduction by the JNK group of MAP kinases Cell 103 2000 239 252
33. G.L. Johnson, and R. Lapadat Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases Science 298 2002 1911 1912
34. J. Wang, Q. Lin, H. Langston, and M.D. Cooper Resident bone marrow macrophages produce type 1 interferons that can selectively inhibit interleukin-7-driven growth of B lineage cells Immunity 3 1995 475 484
35. D.W. Scott, J.H. Chace, G.L. Warner, A. O'Garra, G.G. Klaus, and H. Quill Role of T cell-derived lymphokines in two models of B-cell tolerance Immunol. Rev. 99 1987 153 171
36. G. Haughton, L.W. Arnold, G.A. Bishop, and T.J. Mercolino The CH series of murine B cell lymphomas: neoplastic analogues of Ly-1+ normal B cells Immunol. Rev. 93 1986 35 51
37. C. Rozman, E. Montserrat, N. Vinolas, A. Urbano-Ispizua, J.M. Ribera, T. Gallart, and C. Compernolle Recombinant alpha 2-interferon in the treatment of B chronic lymphocytic leukemia in early stages Blood 71 1988 1295 1298
38. H.E. Heslop, A.C. Bianchi, F.T. Cordingley, M. Turner, W. Chandima, C.P. De Mel, A.V. Hoffbrand, and M.K. Brenner Effects of interferon alpha on autocrine growth factor loops in B lymphoproliferative disorders J. Exp. Med. 172 1990 1729 1734
39. R. Michalevicz, D. Aderka, B. Frisch, and M. Revel Interferon-beta induced remission in a hairy cell leukemia patient resistant to interferon-alpha Leuk. Res. 12 1988 845 851
40. E. Takada, H. Toyota, J. Suzuki, and J. Mizuguchi Prevention of anti-IgM-induced apoptosis accompanying G1 arrest in B lymphoma cells overexpressing dominant-negative mutant form of c-Jun N-terminal kinase 1 J. Immunol. 166 2001 1641 1649
41. E. Takada, H. Toyota, M. Furuhata, J. Suzuki, and J. Mizuguchi Requirement of c-Jun N terminal kinase and P38 mitogen-activated protein kinase for anti-IgM-induced reduction in mitochondrial membrane potential in CH31 B lymphoma cells Immunol. Lett. 81 2002 93 98
42. T. Noutomi, H. Chiba, M. Itoh, H. Toyota, and J. Mizuguchi Bcl-x(L) confers multi-drug resistance in several squamous cell carcinoma cell lines Oral. Oncol. 38 2002 41 48
43. S.Y. Han, S.H. Kim, and L.E. Heasley Differential gene regulation by specific gain-of-function JNK1 proteins expressed in Swiss 3T3 fibroblasts J. Biol. Chem. 277 2002 47167 47174
44. M. Chawla-Sarkar, D.J. Lindner, Y.F. Liu, B.R. Williams, G.C. Sen, R.H. Silverman, and E.C. Borden Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis Apoptosis 8 2003 237 249
45. M.J. de Veer, M. Holko, M. Frevel, E. Walker, S. Der, J.M. Paranjape, R.H. Silverman, and B.R. Williams Functional classification of interferon-stimulated genes identified using microarrays J. Leukocyte Biol. 69 2001 912 920
46. P. Panayiotidis, K. Ganeshaguru, L. Foroni, and A.V. Hoffbrand Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia Leukemia 9 1995 1227 1232
47. C. Selleri, and J.P. Maciejewski The role of FAS-mediated apoptosis in chronic myelogenous leukemia Leuk. Lymphoma 37 2000 283 297
48. D. Donjerkovic, and D.W. Scott Activation-induced cell death in B lymphocytes Cell Res. 10 2000 179 192
49. C.M. Mueller, and D.W. Scott Distinct molecular mechanisms of Fas resistance in murine B lymphoma cells J. Immunol. 165 2000 1854 1862
50. Y. Kim, N. Suh, M. Sporn, and J.C. Reed An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis J. Biol. Chem. 277 2002 22320 22329
51. J. Zhang, J.X. Gao, K. Salojin, Q. Shao, M. Grattan, C. Meagher, D.W. Laird, and T.L. Delovitch Regulation of fas ligand expression during activation-induced cell death in T cells by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase J. Exp. Med. 191 2000 1017 1030
52. A. Mansouri, L.D. Ridgway, A.L. Korapati, Q. Zhang, L. Tian, Y. Wang, Z.H. Siddik, G.B. Mills, and F.X. Claret Sustained activation of JNK-p38 MAP kinase pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells J. Biol. Chem. 278 2003 19245 19256
53. M. Faris, N. Kokot, K. Latinis, S. Kasibhatla, D.R. Green, G.A. Koretzky, and A. Nel The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression J. Immunol. 160 1998 134 144
54. R. Reinehr, F. Schliess, and D. Haussinger Hyperosmolarity and CD95L trigger CD95/EGF receptor association and tyrosine phosphorylation of CD95 as prerequisites for CD95 membrane trafficking and DISC formation FASEB J. 17 2003 731 733
55. C. Tournier, P. Hess, D.D. Yang, J. Xu, T.K. Turner, A. Nimnual, D. Bar-Sagi, S.N. Jones, R.A. Flavell, and R.J. Davis Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway Science 288 2000 870 874
56. L. Thyrell, S. Erickson, B. Zhivotovsky, K. Pokrovskaja, O. Sangfelt, J. Castro, S. Einhorn, and D. Grander Mechanisms of Interferon-alpha induced apoptosis in malignant cells Oncogene 21 2002 1251 1262
57. N. Yanase, K. Ohshima, H. Ikegami, and J. Mizuguchi Cytochrome c release, mitochondrial membrane depolarization, caspase-3 activation, and Bax-alpha cleavage during IFN-alpha-induced apoptosis in Daudi B lymphoma cells J. Interferon Cytokine Res. 20 2000 1121 1129